[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:medulloblastoma":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":208,"states":219},"Medulloblastoma",32,26,[8,16,22,29,35,42,49,55,61,67,73,78,84,90,96,102,108,114,120,127,133,140,146,152,158,164,170,177,183,189,195,202],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06701812","Digoxin Medulloblastoma Study",[12],"Phase 2","RECRUITING","2026-08-26T02:15:00.557154Z","2026-05-05T02:43:29.393271Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":20,"content_modified":21},"NCT05535166","Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma",[12],"2026-08-26T02:16:16.169331Z","2026-05-05T02:43:28.846293Z",{"nct_id":23,"title":24,"phases":25,"status":13,"updated_at":27,"content_modified":28},"NCT07346157","Liothyronine in Combination With BIT Regimen for Medulloblastoma With or Without Minimal Residual Disease",[26],"Phase 1\u002FPhase 2","2026-08-26T02:15:53.461103Z","2026-05-05T02:43:28.656974Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT04696029","DFMO as Maintenance Therapy for Molecular High\u002FVery High Risk and Relapsed Medulloblastoma",[12],"2026-08-26T02:18:26.129155Z","2026-05-05T02:43:27.838334Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":40,"content_modified":41},"NCT07492316","RNA-lipid Particle (RNA-LP) Vaccines for Recurrent\u002FProgressive Medulloblastoma (MB)",[39],"Phase 1","2026-08-26T02:19:21.761002Z","2026-05-05T02:43:27.429137Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":47,"content_modified":48},"NCT05382338","A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss",[46],"Phase 3","2026-08-26T02:16:59.895916Z","2026-05-05T02:43:27.063287Z",{"nct_id":50,"title":51,"phases":52,"status":13,"updated_at":53,"content_modified":54},"NCT05096481","PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma",[12],"2026-08-26T02:16:36.513735Z","2026-05-05T02:43:29.390899Z",{"nct_id":56,"title":57,"phases":58,"status":13,"updated_at":59,"content_modified":60},"NCT01356290","Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors",[12],"2026-08-26T02:18:41.390601Z","2026-05-05T02:43:29.166226Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT05106296","Chemo-immunotherapy Using Ibrutinib Plus Indoximod for Patients With Pediatric Brain Cancer",[39],"2026-08-26T02:19:06.150683Z","2026-05-05T02:43:27.323359Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT06624371","Atovaquone Combined With Radiation in Children With Malignant Brain Tumors",[39],"2026-08-26T02:15:13.282904Z","2026-05-05T02:35:31.758752Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":20,"content_modified":77},"NCT03911388","HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors",[39],"2026-07-30T01:46:14.458417Z",{"nct_id":79,"title":80,"phases":81,"status":13,"updated_at":82,"content_modified":83},"NCT05278208","Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors",[26],"2026-08-26T02:18:21.216897Z","2026-07-24T01:27:14.928126Z",{"nct_id":85,"title":86,"phases":87,"status":13,"updated_at":88,"content_modified":89},"NCT06639607","PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma\u002FHigh-grade Glioma and Recurrent Diffuse Midline Glioma\u002FHigh-grade Glioma, Medulloblastoma, and Ependymoma",[26],"2026-08-03T00:58:26.564367Z","2026-07-05T05:32:16.689130Z",{"nct_id":91,"title":92,"phases":93,"status":13,"updated_at":94,"content_modified":95},"NCT06193759","Immunotherapy for Malignant Pediatric Brain Tumors Employing Adoptive Cellular Therapy (IMPACT)",[39],"2026-08-26T02:18:25.327036Z","2026-06-17T21:13:38.320470Z",{"nct_id":97,"title":98,"phases":99,"status":13,"updated_at":100,"content_modified":101},"NCT04541082","Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms",[39],"2026-08-26T02:18:37.277498Z","2026-05-05T02:43:29.163334Z",{"nct_id":103,"title":104,"phases":105,"status":13,"updated_at":106,"content_modified":107},"NCT04185038","Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma\u002FDiffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors",[39],"2026-08-26T02:18:51.833592Z","2026-05-05T02:43:28.903254Z",{"nct_id":109,"title":110,"phases":111,"status":13,"updated_at":112,"content_modified":113},"NCT07087002","GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults",[39],"2026-08-26T02:19:23.493898Z","2026-05-05T02:43:28.714199Z",{"nct_id":115,"title":116,"phases":117,"status":13,"updated_at":118,"content_modified":119},"NCT06161519","PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications",[26],"2026-08-26T02:16:39.977107Z","2026-05-05T02:43:28.398018Z",{"nct_id":121,"title":122,"phases":123,"status":13,"updated_at":125,"content_modified":126},"NCT07017816","A Phase 0\u002F1 Study of cDNA for TP53, Checkpoint Inhibition and Radiation in Children With Recurrent, Progressive or Refractory CNS Malignancies.",[124],"Early Phase 1","2026-08-26T02:17:32.059863Z","2026-05-05T02:43:27.319544Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT04099797","C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)",[39],"2026-08-26T02:16:22.235886Z","2026-05-05T02:43:27.089113Z",{"nct_id":134,"title":135,"phases":136,"status":13,"updated_at":138,"content_modified":139},"NCT04081701","68-Ga DOTATATE PET\u002FMRI in the Diagnosis and Management of Somatostatin Receptor Positive CNS Tumors.",[137],"Phase 4","2026-08-26T02:15:09.079045Z","2026-05-05T02:43:27.179150Z",{"nct_id":141,"title":142,"phases":143,"status":13,"updated_at":144,"content_modified":145},"NCT07085325","CSIMEMPHIS: Long-term Follow-up of Medulloblastoma Survivors That Received Craniospinal Irradiation",[],"2026-08-26T02:16:34.792807Z","2026-07-19T19:36:05.060361Z",{"nct_id":147,"title":148,"phases":149,"status":13,"updated_at":150,"content_modified":151},"NCT06514898","Adoptive T Cell Therapy, DC Vaccines, and Hematopoietic Stem Cells Combined With Immune checkPOINT Blockade in Patients With Medulloblastoma",[39],"2026-08-26T02:17:05.997056Z","2026-06-14T18:39:22.236841Z",{"nct_id":153,"title":154,"phases":155,"status":13,"updated_at":156,"content_modified":157},"NCT07242963","Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study",[],"2026-08-26T02:16:54.876240Z","2026-05-13T02:55:06.680777Z",{"nct_id":159,"title":160,"phases":161,"status":13,"updated_at":162,"content_modified":163},"NCT07698899","A Study of 177Lu-DTPA-Omburtamab in Children and Adolescents With Brain Cancer or Cancer That Has Spread to the Central Nervous System (CNS)",[39],"2026-08-26T02:18:49.989941Z","2026-07-19T19:36:05.081790Z",{"nct_id":165,"title":166,"phases":167,"status":13,"updated_at":168,"content_modified":169},"NCT05057702","Individualized Treatment Plan in Children and Young Adults With Relapsed Medulloblastoma and Ependymoma",[],"2026-08-26T02:17:57.997171Z","2026-05-05T02:43:27.628617Z",{"nct_id":171,"title":172,"phases":173,"status":174,"updated_at":175,"content_modified":176},"NCT07291102","Comparison of Neurocognitive Outcome in Two Standard Regimen for Treatment of Low-risk Medulloblastoma",[46],"NOT_YET_RECRUITING","2026-08-26T02:18:06.247899Z","2026-05-05T02:43:27.304982Z",{"nct_id":178,"title":179,"phases":180,"status":174,"updated_at":181,"content_modified":182},"NCT07039760","Asciminib With or Without Sildenafil for Brain Tumors",[124],"2026-08-26T02:16:57.705506Z","2026-07-05T05:32:16.728525Z",{"nct_id":184,"title":185,"phases":186,"status":174,"updated_at":187,"content_modified":188},"NCT07390539","B7-H3.CD28Z.CART in CNS Neoplasms",[39],"2026-08-26T02:15:10.362237Z","2026-05-05T02:43:29.514138Z",{"nct_id":190,"title":191,"phases":192,"status":174,"updated_at":193,"content_modified":194},"NCT07516353","my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults",[],"2026-08-26T02:16:01.079019Z","2026-05-05T02:43:29.524607Z",{"nct_id":196,"title":197,"phases":198,"status":199,"updated_at":200,"content_modified":201},"NCT04337177","Flavored, Oral Irinotecan VAL-413 (Orotecan®) Given With Temozolomide for Treatment of Recurrent Pediatric Solid Tumors",[39],"ACTIVE_NOT_RECRUITING","2026-08-03T03:02:58.488119Z","2026-05-05T02:43:28.743177Z",{"nct_id":203,"title":204,"phases":205,"status":199,"updated_at":206,"content_modified":207},"NCT05835687","Loc3CAR: Locoregional Delivery of B7-H3-CAR T Cells for Pediatric Patients With Primary CNS Tumors",[39],"2026-08-03T03:23:28.660374Z","2026-05-05T02:43:27.753658Z",[209,213,216],{"biomarker":210,"count":211,"slug":212},"CD276 wt Allele",3,"cd276-wt-allele",{"biomarker":214,"count":211,"slug":215},"Histone H3 Lysine 28","histone-h3-lysine-28",{"biomarker":217,"count":211,"slug":218},"Sonic Hedgehog Protein","sonic-hedgehog-protein",[220,224,228,231,235,238,242,245,249,252,255,258,262,265,268,271,274,277,280,283,286,289],{"state":221,"count":222,"slug":223},"Texas",10,"texas",{"state":225,"count":226,"slug":227},"District of Columbia",9,"district-of-columbia",{"state":229,"count":226,"slug":230},"Missouri","missouri",{"state":232,"count":233,"slug":234},"California",7,"california",{"state":236,"count":233,"slug":237},"Florida","florida",{"state":239,"count":240,"slug":241},"North Carolina",6,"north-carolina",{"state":243,"count":240,"slug":244},"Tennessee","tennessee",{"state":246,"count":247,"slug":248},"Massachusetts",5,"massachusetts",{"state":250,"count":247,"slug":251},"New York","new-york",{"state":253,"count":247,"slug":254},"Ohio","ohio",{"state":256,"count":247,"slug":257},"Pennsylvania","pennsylvania",{"state":259,"count":260,"slug":261},"Alabama",4,"alabama",{"state":263,"count":260,"slug":264},"Georgia","georgia",{"state":266,"count":260,"slug":267},"Illinois","illinois",{"state":269,"count":260,"slug":270},"Maryland","maryland",{"state":272,"count":260,"slug":273},"Michigan","michigan",{"state":275,"count":211,"slug":276},"Arkansas","arkansas",{"state":278,"count":211,"slug":279},"Colorado","colorado",{"state":281,"count":211,"slug":282},"Connecticut","connecticut",{"state":284,"count":211,"slug":285},"Minnesota","minnesota",{"state":287,"count":211,"slug":288},"New Jersey","new-jersey",{"state":290,"count":211,"slug":291},"Washington","washington"]